Details for New Drug Application (NDA): 011120
✉ Email this page to a colleague
NDA 011120 describes THORAZINE, which is a drug marketed by Glaxosmithkline and is included in two NDAs. Additional details are available on the THORAZINE profile page.
The generic ingredient in THORAZINE is chlorpromazine. There are twenty-four drug master file entries for this compound. Additional details are available on the chlorpromazine profile page.
The generic ingredient in THORAZINE is chlorpromazine. There are twenty-four drug master file entries for this compound. Additional details are available on the chlorpromazine profile page.
Summary for 011120
| Tradename: | THORAZINE |
| Applicant: | Glaxosmithkline |
| Ingredient: | chlorpromazine hydrochloride |
| Patents: | 0 |
Profile for product number 016
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 30MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 017
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 75MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 018
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 150MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
